Printer Friendly

NORTRAN PHARMACEUTICALS ANNOUNCES KEY APPOINTMENT TO BOARD OF DIRECTORS

 NORTRAN PHARMACEUTICALS ANNOUNCES KEY APPOINTMENT
 TO BOARD OF DIRECTORS
 VANCOUVER, British Columbia, Aug. 4 /PRNewswire/ -- Nortran Pharmaceuticals Inc. (Vancouver: NRT) announced the appointment of James J. Miller, Ph.D., to the board of directors. Miller was co-founder and until recently the chairman, president and chief executive officer of one of Canada's leading biotechnology and pharmaceutical companies, Quadra Logic Technologies Inc.
 Miller's medical and scientific background together with his business experience will be a welcome addition to the pharmaceutical and medical technology development program being undertaken by Dr. Michael Walker, Nortran's chief scientist and president of Nortran's 50 percent-owned research and development company, Rhythm Search Developments Ltd.
 The board of directors is now comprised of the following individuals:
 J. Terry Alexander Douglas McRae
 Michael Walker Steven Wong
 Gordon Politeski James Miller
 -0- 8/4/92
 /CONTACT: David Robinson of Nortran, 604-685-7933 or U.S. toll- free, 800-665-7037/
 (NRT.) CO: Nortran Pharmaceuticals Inc. ST: British Columbia IN: MTC SU: PER


EH -- LA001 -- 6528 08/04/92 09:34 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 4, 1992
Words:167
Previous Article:SAFEGUARD HEALTH ENTERPRISES INC. REPORTS SUBSTANTIAL INCREASE IN SECOND QUARTER NET INCOME AND EARNINGS
Next Article:JENNY CRAIG, INC. ANNOUNCES EARNINGS
Topics:


Related Articles
NORTRAN RESOURCES LTD. ANNOUNCES EQUITY ACQUISITION
NORTRAN RESOURCES LTD. ANNOUNCES APPOINTMENT OF GORDON POLITESKI AS PRESIDENT AND DIRECTOR
ICN AND SUBSIDIARY COMPANIES ANNOUNCE MANAGEMENT APPOINTMENTS
CELLEGY NAMES NEW BOARD MEMBER
CORTEX APPOINTS DAVIS TEMPLE, Ph.D., TO BOARD OF DIRECTORS
COPLEY PHARMACEUTICAL, INC. NAMES GABRIEL R. CIPAU, PH.D., PRESIDENT, CEO AND BOARD MEMBER;
ADVANCED PLANT PHARMACEUTICALS INC. ANNOUNCES APPOINTMENT OF NEW SCIENTIFIC DIRECTOR AND NEW FINANCIAL CONTROLLER
Scandipharm Announc
Sheffield Medical Technologies Names John M. Bailey and Digby W. Barrios to Board
Pharmaceutical Product Development, Inc. Names Dr. Loren Miller Executive Director, Regulatory and Product Development

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters